India’s capital markets regulator is likely to reduce margins on equity derivatives on non-expiry days to encourage big traders to place longer-term bets rather than focus solely on the expiration day ...

NEW DELHI: Prices of key inputs for the fast-moving consumer goods (FMCG) sector are moving in opposite directions, creating a mixed margin outlook for companies such as Hindustan Unilever, Marico and ...

The Coca-Cola Company KO delivered a notable margin performance in third-quarter 2025, underscoring the growing impacts of its multi-year productivity and efficiency initiatives. While the comparable ...

IT IS THAT time in chief executives’ calendars when they start asking ChatGPT to draft their end-of-year memos. If they run an American company, the artificially intelligent speechwriter has plenty of ...

Applied Materials’ AMAT gross margin came in at 48.8% in the fourth quarter of fiscal 2025, up 120 basis points year over year. The positive momentum in the gross margin has been there for the past ...

Margin debt’s recent jump to a new high is potentially worrying. But it’s not clear just how much. Margin debt reflects how much investors have borrowed from their brokers to purchase more stocks. It ...

Investors buying stocks with borrowed money suggests confidence that the market will keep rising. If only that were true. Margin debt's recent jump to a new high is potentially worrying. But it's not ...

Ripple effect: Microsoft has cut more than 27,000 jobs since early 2020, with the Xbox division hit especially hard, even as the company raises Game Pass fees and console prices. The aggressive ...

Many nonprofit hospitals and health systems have made steady progress on financial turnarounds since the end of the COVID-19 pandemic — though others continue to struggle — but new and persistent ...

Hospitals’ operating margins continued to soften through July as volumes remained strong, but spending on supplies and drugs inched upward, according to Kaufman Hall’s latest monthly performance ...

In a retrospective cohort of patients with melanoma in situ (MIS) with non-lentigo maligna/non-acral lentiginous (non-LM/non-ALM) subtypes, no local recurrences, metastases, or melanoma-specific ...